CSS LLC’s Altimmune ALT Stock Holding History

CSS LLC’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-66,600	Closed	-$657K	–	1174
2021 Q2	$657K	Buy	+66,600	New	+$911K	0.03%	525
2021 Q1	–	Sell	-10,000	Closed	-$113K	–	919
2020 Q4	$113K	Buy	+10,000	New	+$118K	﹤0.01%	695

Other funds holding ALT

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

CSS LLC's ALT Position: Q4 2022 in Review

CSS LLC sold out of Altimmune (ALT) in Q4 2022, closing a stake of 20,546 shares — an estimated $231K sold.

CSS LLC first reported a position in ALT in Q3 2020 and held it in 5 quarters. The position peaked at $489K in Q1 2021. 128 funds tracked by Wall St. Rank hold ALT as of Q4 2022.

CSS LLC reported no remaining Altimmune position as of Q4 2022 after selling out during the quarter.
CSS LLC sold 20,546 Altimmune shares in Q4 2022, an estimated $231K.
CSS LLC first reported a position in Altimmune in Q3 2020 and held it in 5 quarters.
CSS LLC's Altimmune position peaked at $489K in Q1 2021.
128 funds tracked by Wall St. Rank held Altimmune as of Q4 2022.

Based on CSS LLC's 13F filing for Q4 2022, filed 14 Feb 2023.